Identification and characterization of unknown oxidation degradation products of Rimegepant by HPLC and triple quadrupole mass spectrometry
European Journal of Mass Spectrometry · 2025-02 · 31 (1-2) · 38-50
DOI: 10.1177/14690667251328804 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Mass Spectrometry, online erschienen am 26.03.2025. Verfasst von Narayana Reddy Godi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, School of Pharmacy, Anurag University, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Pyridines, Mass Spectrometry, Tandem Mass Spectrometry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Rimegepant is a calcitonin gene-related peptide receptor antagonist that has been licensed for migraine headache treatment in the United States, the European Union, the United Kingdom, Hong Kong, Australia, and Kuwait. The oxidation stress study of the Rimegepant drug substance revealed the presence of five impurities. Rimegepant degraded by 5% under the selected oxidation conditions, meeting regulatory expectations. Four out of five impurities are enhanced by more than 1%. This research aims to characterize these oxidation degradation products utilizing the triple quadrupole mass spectroscopic technique. The Rimegepant oxidation degradation products were identified using an optimized chromatographic method that relies on reverse-phase HPLC with PDA detection. This technique utilized a Waters Xbridge C18 column with an eluent mixture of acetonitrile and 0.1% formic acid in water. The oxidation products of Rimegepant have been effectively separated, with a resolution above 3.0. Triple quadrupole mass spectrometry analysis characterized the five degradation products, which showed three N-oxide impurities with masses m / z 566, m / z 550, and m / z 548, as well as two hydrolysis products with masses, m / z 218, m / z 290. These new impurities deserve special attention because the drug's potency and related impurity levels determine any pharmaceutical medication product's quality, safety, and effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, School of Pharmacy, Anurag University, Hyderabad, Telangana, India.
- Industrial Chemical Product Development and Analysis Centre, Department of Chemistry, GITAM School of Science, GITAM Deemed to be University - Bengaluru Campus, Bengaluru, Karnataka, India.
- Department of Chemistry, College of Engineering, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India.
ORCID-Profile: Narayana Reddy Godi, Sireesha Dodda, Nagavardhana Reddy Vanga, Kumarswamy Ummiti
Zitieren
APA
Godi, N. R., Dodda, S., Vanga, N. R., & Ummiti, K. (2025). Identification and characterization of unknown oxidation degradation products of Rimegepant by HPLC and triple quadrupole mass spectrometry. European Journal of Mass Spectrometry, 31(1-2), 38-50. https://doi.org/10.1177/14690667251328804
Vancouver
Godi NR, Dodda S, Vanga NR, Ummiti K. Identification and characterization of unknown oxidation degradation products of Rimegepant by HPLC and triple quadrupole mass spectrometry. European Journal of Mass Spectrometry. 2025;31(1-2):38-50. doi:10.1177/14690667251328804
BibTeX
@article{Godi2025,
author = {Godi, Narayana Reddy and Dodda, Sireesha and Vanga, Nagavardhana Reddy and Ummiti, Kumarswamy},
title = {Identification and characterization of unknown oxidation degradation products of Rimegepant by HPLC and triple quadrupole mass spectrometry},
journal = {European Journal of Mass Spectrometry},
year = {2025},
volume = {31},
number = {1-2},
pages = {38--50},
doi = {10.1177/14690667251328804}
}
EUVIMED